Hygeia
Hygeia is a oncology healthcare company.
Hygeia, founded in 2009 and headquartered in Shanghai, is a provider of oncology medical services. The founder is Zhu Yiwen. Listed on the Hong Kong Stock Exchange on June 29, 2020, the company’s major shareholders are Harmony Healthcare and Fountain Grass. Rivals that have direct and indirect competition with Hygeia include Kangji Medical Holdings Limited, Gan&Lee Pharmaceuticals, Immunotech Biopharm Ltd..
Medtronic's world's first self expanding pulmonary valve was first-class recalled
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Technology, Consumer Staples, Real EstateTech for Global, Globalization Footprints of the Established and the New
Research
Technology, Consumer Staples, Real EstateLow-Carbon Industry Expansion - Key Studies From Chinese Companies
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Smart IT provider Weimei Health Raises Tens of Millions of CNY in Angel Funding
Dedicated to hospital management informatization, Weimei Health provides intelligent solutions for the medical information industry. Its new generation of intelligent hospital management system integrates different directions of clinic workflows and makes it more intensive and systematic through integration and reconstruction.
May 11, 2022 03:41 PM
Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan
Ping An Health's 2021 annual report was released, with a revenue of 7.3 billion yuan, a year-on-year increase of 8%
Hong Kong Pharmaceutical stocks plunged straight in the afternoon
Software Developer King’s Soft Raises Tens of Millions of CNY in Series A+ Financing Round
The company will accelerate its deployment in the field of laboratory automation, especially the application in the fields of biomedicine and life sciences such as new drug research and development, gene sequencing, and clinical diagnosis.
May 10, 2022 11:13 AM
"Tiandu technology" won tens of millions of yuan of seed round financing, and AI computing enabled the innovative drug industry
Representative Li Yanping: further improve medical services for the elderly and actively respond to the challenges of aging
The world's first pig heart transplant patient died two months after the operation, and the cause of death is not clear
Gan liming, former vice president of global R & D of AstraZeneca, became president and chief medical officer of global R & D of Ruibo biology